Business, Cultural Corner, Healthcare, Science

IVI RMA North America expands Southern California presence with acquisition of Reproductive Health and Wellness Center, Rise Fertility, and Halo Fertility from Global Premier Fertility

Leading Southern California clinics join Premier North American Fertility Network   BASKING RIDGE, N.J. — (BUSINESS WIRE) — IVI RMA North America, a leader in fertility care and assisted reproduction, Tuesday announced it completed the acquisition of three prominent Southern California-based fertility

Business, Healthcare, Local News

US Food and Drug Administration approves Opdivo Qvantig™ (nivolumab and hyaluronidase-nvhy) injection, for subcutaneous use in most previously approved adult, solid tumor Opdivo® (nivolumab) indications1,2

Opdivo Qvantig is the first and only subcutaneously administered PD-1 inhibitor1 Given over three- to five-minutes, Opdivo Qvantig demonstrated consistent efficacy and showed a comparable safety profile tointravenous Opdivo in the Phase 3 CheckMate-67T trial1,3     PRINCETON, N.J. — (BUSINESS WIRE)